Stevanato Group announces the entrance of Fabrizio Bonanni in the Board of Directors
Stevanato Group announces that Dr. Fabrizio Bonanni joined the Company as member of the Board of Directors. Dr. Bonanni boasts a large experience in the biopharmaceutical field, thanks to his previous involvement in two large American multinational companies.
Dr. Bonanni just stepped down from Amgen, where he held the position of Executive Vice President of Operations. In the same company, he previously served as Senior Vice President, Manufacturing and Senior Vice President, Quality & Compliance.
Prior to Amgen he served in positions of increasing leadership responsibility in quality, manufacturing and regulatory/clinical affairs at Baxter International.
Dr. Bonanni commented "I am delighted to contribute to Stevanato Group's success. Its commitment in ensuring that medicines flow intact to patients motivates me with new ideas. Being part of a company whose main objective is to always guarantee the highest quality of glass pharmaceutical containers is an honor."
Cav. Sergio Stevanato, President of Stevanato Group, stated: "I am glad that Fabrizio joined our Board of Directors. His deep experience in the pharmaceutical field will give a strong contribution and influence in Stevanato Group's future decisions. To benefit from his knowledge in the regulatory area gives to the Group a great opportunity."
Released September 25, 2013